Target intelligence / Profile preview

Phosphoenolpyruvate:sugar phosphotransferase system (PTS)

Target
PTS
Molecular classification
Transporter, Enzyme, Multicomponent signaling complex
01

Overview

The Phosphoenolpyruvate:sugar phosphotransferase system (PTS) is a sophisticated multicomponent system found exclusively in bacteria that facilitates the uptake and concomitant phosphorylation of various simple sugars, such as glucose, mannose, and fructose. It utilizes phosphoenolpyruvate (PEP) as an energy source and phosphoryl donor, transferring a phosphate group through a cascade of proteins (Enzyme I, HPr, and Enzyme II) to the incoming sugar. Beyond its primary role in nutrient acquisition, the PTS acts as a global regulatory hub, controlling carbon catabolite repression and the expression of virulence factors in response to environmental nutrient availability. Because the system is absent in humans and essential for the survival and pathogenicity of many bacteria, it is a high-priority target for the development of novel, narrow-spectrum antibacterial agents. Inhibiting the PTS can effectively starve the pathogen and disrupt its ability to adapt to the host environment, although therapeutic challenges include the risk of affecting beneficial commensal bacteria.

Other names
PEP-dependent phosphotransferase systemSugar phosphotransferase systemBacterial PTSPhosphotransferase systemPTS sugar transporters
02

Mechanism of action

Inhibition of sugar translocation and phosphorylation; disruption of carbon catabolite repression (CCR) and intracellular signaling cascades.

03

Biological functions

Carbohydrate transportSignal transductionCatabolite repressionMetabolismBiofilm formationVirulence regulation
04

Disease associations

InfectionBacterial virulenceAntimicrobial resistance
05

Safety considerations

Disruption of the human gut microbiome (dysbiosis)Potential for rapid development of resistance via alternative transport pathways (e.g., ABC transporters)Narrow spectrum of activity against non-PTS utilizing microbes
06

Interacting drugs

Sublancin

4 more in the full profile.

07

Biomarkers

Intracellular cyclic AMP (cAMP) levelsSugar consumption ratesPhosphorylation state of HPr/Enzyme IIBacterial growth rate in glucose-limited media

Beyond the preview

Go deeper on Phosphoenolpyruvate:sugar phosphotransferase system (PTS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphoenolpyruvate:sugar phosphotransferase system (PTS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call